pubmed-article:11216963 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:11216963 | lifeskim:mentions | umls-concept:C1956346 | lld:lifeskim |
pubmed-article:11216963 | lifeskim:mentions | umls-concept:C0038435 | lld:lifeskim |
pubmed-article:11216963 | lifeskim:mentions | umls-concept:C0031001 | lld:lifeskim |
pubmed-article:11216963 | lifeskim:mentions | umls-concept:C0042402 | lld:lifeskim |
pubmed-article:11216963 | lifeskim:mentions | umls-concept:C0162680 | lld:lifeskim |
pubmed-article:11216963 | lifeskim:mentions | umls-concept:C1511790 | lld:lifeskim |
pubmed-article:11216963 | lifeskim:mentions | umls-concept:C0303611 | lld:lifeskim |
pubmed-article:11216963 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
pubmed-article:11216963 | lifeskim:mentions | umls-concept:C1366036 | lld:lifeskim |
pubmed-article:11216963 | lifeskim:mentions | umls-concept:C0040399 | lld:lifeskim |
pubmed-article:11216963 | lifeskim:mentions | umls-concept:C0243067 | lld:lifeskim |
pubmed-article:11216963 | lifeskim:mentions | umls-concept:C2349975 | lld:lifeskim |
pubmed-article:11216963 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:11216963 | pubmed:dateCreated | 2001-2-16 | lld:pubmed |
pubmed-article:11216963 | pubmed:abstractText | We prospectively compared dipyridamole single-photon emission computed tomography (SPECT) imaging with Tc-99m sestamibi and Tc-99m tetrofosmin for the detection of reversible perfusion defects in patients with mild-to-moderate coronary artery disease. | lld:pubmed |
pubmed-article:11216963 | pubmed:language | eng | lld:pubmed |
pubmed-article:11216963 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11216963 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:11216963 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11216963 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11216963 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11216963 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11216963 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11216963 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11216963 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:11216963 | pubmed:month | Feb | lld:pubmed |
pubmed-article:11216963 | pubmed:issn | 0735-1097 | lld:pubmed |
pubmed-article:11216963 | pubmed:author | pubmed-author:LahiriAA | lld:pubmed |
pubmed-article:11216963 | pubmed:author | pubmed-author:DePueyE GEG | lld:pubmed |
pubmed-article:11216963 | pubmed:author | pubmed-author:TailleferRR | lld:pubmed |
pubmed-article:11216963 | pubmed:author | pubmed-author:UdelsonJ EJE | lld:pubmed |
pubmed-article:11216963 | pubmed:author | pubmed-author:SmythV GVG | lld:pubmed |
pubmed-article:11216963 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:11216963 | pubmed:volume | 37 | lld:pubmed |
pubmed-article:11216963 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:11216963 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:11216963 | pubmed:pagination | 458-62 | lld:pubmed |
pubmed-article:11216963 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:11216963 | pubmed:meshHeading | pubmed-meshheading:11216963... | lld:pubmed |
pubmed-article:11216963 | pubmed:meshHeading | pubmed-meshheading:11216963... | lld:pubmed |
pubmed-article:11216963 | pubmed:meshHeading | pubmed-meshheading:11216963... | lld:pubmed |
pubmed-article:11216963 | pubmed:meshHeading | pubmed-meshheading:11216963... | lld:pubmed |
pubmed-article:11216963 | pubmed:meshHeading | pubmed-meshheading:11216963... | lld:pubmed |
pubmed-article:11216963 | pubmed:meshHeading | pubmed-meshheading:11216963... | lld:pubmed |
pubmed-article:11216963 | pubmed:meshHeading | pubmed-meshheading:11216963... | lld:pubmed |
pubmed-article:11216963 | pubmed:meshHeading | pubmed-meshheading:11216963... | lld:pubmed |
pubmed-article:11216963 | pubmed:meshHeading | pubmed-meshheading:11216963... | lld:pubmed |
pubmed-article:11216963 | pubmed:meshHeading | pubmed-meshheading:11216963... | lld:pubmed |
pubmed-article:11216963 | pubmed:meshHeading | pubmed-meshheading:11216963... | lld:pubmed |
pubmed-article:11216963 | pubmed:meshHeading | pubmed-meshheading:11216963... | lld:pubmed |
pubmed-article:11216963 | pubmed:meshHeading | pubmed-meshheading:11216963... | lld:pubmed |
pubmed-article:11216963 | pubmed:meshHeading | pubmed-meshheading:11216963... | lld:pubmed |
pubmed-article:11216963 | pubmed:meshHeading | pubmed-meshheading:11216963... | lld:pubmed |
pubmed-article:11216963 | pubmed:meshHeading | pubmed-meshheading:11216963... | lld:pubmed |
pubmed-article:11216963 | pubmed:year | 2001 | lld:pubmed |
pubmed-article:11216963 | pubmed:articleTitle | Enhanced detection of reversible perfusion defects by Tc-99m sestamibi compared to Tc-99m tetrofosmin during vasodilator stress SPECT imaging in mild-to-moderate coronary artery disease. | lld:pubmed |
pubmed-article:11216963 | pubmed:affiliation | Department of Cardiovascular Medicine, Northwick Park & St. Marks Hospitals, NHS Trust and Institute of Medical Research, Harrow, United Kingdom. | lld:pubmed |
pubmed-article:11216963 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:11216963 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:11216963 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11216963 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11216963 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11216963 | lld:pubmed |